Progenics Pharm Stock Price, News & Analysis

PGNX NASDAQ

Company Description

Progenics Pharm (NASDAQ: PGNX) is a publicly traded biotechnology company in the Health Technology sector.

PGNX stock has declined 16.0% over the past year.

This page provides a comprehensive overview of PGNX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-15.98%

Performance 1 year

$0.0

Market Cap

86.6M

Shares outstanding

Progenics Pharm (PGNX) stock. Over the past 12 months, the stock has lost 16.0%.

Latest News

View All

No recent news available for PGNX.

SEC Filings

View All

No SEC filings available for PGNX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PGNX Company Profile & Sector Positioning

Progenics Pharm (PGNX) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.